title: An unusual neuropathy in a diabetic patient: evidence for intravenous immunoglobin-induced effective therapy.
abstract: We report the case of a 68-year old type-2 diabetic male patient who was admitted to hospital for progressive weakness in the right lower limb. Although his metabolic control was good, he lost more than 20 kg of weight. Despite intensive physio- and vitaminotherapy, his neurological condition kept on degrading with a severe amyotrophy and pain of the right thigh. He was unable to walk and to stand alone. Besides a yet known sensitive polyneuropathy, the electrophysiological study revealed an obvious motor involvement with signs of demyelination and axonal degeneration. Combined with the albuminocytologic dissociation observed in the cerebrospinal fluid, these specific clinical and electrophysiological features led us to postulate a diagnosis of inflammatory neuropathy. The patient underwent a treatment by methylprednisolone and immunoglobins that rapidly induced a striking improvement of his neurological condition. This case report illustrates that rare forms of neuropathy such as inflammatory neuropathies close to chronic inflammatory demyelinating polyneuropathy (CIDP) can occur in diabetic patients and superimpose on the more commonly described forms of neuropathies. It recalls the importance of recognizing CIDP-like neuropathies because unlike other forms of neuropathy, inflammatory neuropathies are perfectly curable.
authors.affiliation: Department of Internal Medicine, CHR-St Joseph Medical Center, Mons, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: Romedenne
authors.forename: R
authors.initials: R
authors.lastname: Mukendi
authors.forename: P
authors.initials: P
authors.lastname: Stasse
authors.forename: P
authors.initials: P
authors.lastname: Indekeu
authors.forename: M
authors.initials: M
authors.lastname: Buysschaert
authors.forename: I M
authors.initials: IM
authors.lastname: Colin
mesh_terms: D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D011115:Polyneuropathies / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D001786:Blood Glucose; D016756:Immunoglobulins, Intravenous; D007328:Insulin; D008775:Methylprednisolone